Use of nilotinib in the diabetic patient
A 42-year-old man, diabetic patient, after CML Ph+ diagnosis started a treatment with imatinib reaching both CHR and CCyR within 6 months. Because of two episodes of vitreous haemorrhage the treatment was discontinued for four months with the lost of the CCyR and the maintenance of the CHR. The pati...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SEEd
2015-10-01
|
| Col·lecció: | Clinical Management Issues |
| Matèries: | |
| Accés en línia: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1094 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|